Atlas Trials

Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients With Metastatic Colorectal Cancer

Clinical trial NCT02181556 · COMPLETED

Trial details

NCT number
NCT02181556
Sponsor
Federation Francophone de Cancerologie Digestive
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2014-10-01
Primary completion
2017-02-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.